Estefania Linares Espinos
Research Subjects
Research Interests
Estefania Linares Espinos has a total of 242 co-authors. Here are the top co-authors by number of shared publications:
- Paolo Gontero
Department of Urology, Città della Salute e della Scienza University of Torino School of Medicine Torino Italy
8 shared publications Daniel Vergho
Würzburg, Germany
7 shared publicationsFrancesco Montorsi
Milan, Italy
7 shared publicationsJohn A. Libertino
Boston, MA
7 shared publicationsRichard Zigeuner
Graz, Germany
7 shared publicationsSascha Pahernik
Heidelberg, Germany
7 shared publications
Latest Publications
- Open Access
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1268-e1269
Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1268-e1269
Open AccessPredictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
- Open Access
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1278-e1279
Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1278-e1279
Open AccessProposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4) , e633
MP48-19 ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN MINIMALLY INVASIVE APPROACH FOR KIDNEY CANCER WITH VENOUS THROMBUS: A MULTICENTRIC STUDY.
In case of localised kidney cancer (KC) without venous thrombus (VT) minimally invasive (MI) procedure are largely used. However little evidence exists on this approach for the treatment of KC with VT of which the standard treatment remains radical nephrectomy (RN) ± thrombectomy.
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4) , e633
MP48-19 ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN MINIMALLY INVASIVE APPROACH FOR KIDNEY CANCER WITH VENOUS THROMBUS: A MULTICENTRIC STUDY.
In case of localised kidney cancer (KC) without venous thrombus (VT) minimally invasive (MI) procedure are largely used. However little evidence exists on this approach for the treatment of KC with VT of which the standard treatment remains radical nephrectomy (RN) ± thrombectomy.
- 1 January 2018
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 42 (1) , 17-24
Indicación de cistectomía precoz en el cáncer vesical no músculo infiltrante. Revisión de la literatura
- 1 January 2018
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 42 (1) , 17-24
Indicación de cistectomía precoz en el cáncer vesical no músculo infiltrante. Revisión de la literatura
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , e630-e631
MP47-07 SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: ONCOLOGIC AND FUNCTIONAL OUTCOMES FROM TWO HIGH-VOLUME INSTITUTIONS
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , e630-e631
MP47-07 SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: ONCOLOGIC AND FUNCTIONAL OUTCOMES FROM TWO HIGH-VOLUME INSTITUTIONS
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , e66-e67
PD04-10 EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS
Several prognostic tools have been developed for patients with renal cell carcinoma (RCC). However, those calculators usually consider T3 tumors a single entity and little is known of their performance in patients with tumor thrombus. We assess the value of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) score for prognosis of cancer-specific survival (CSS) in a large multicenter patient cohort with RCC and venous tumor thrombus.
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , e66-e67
PD04-10 EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS
Several prognostic tools have been developed for patients with renal cell carcinoma (RCC). However, those calculators usually consider T3 tumors a single entity and little is known of their performance in patients with tumor thrombus. We assess the value of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) score for prognosis of cancer-specific survival (CSS) in a large multicenter patient cohort with RCC and venous tumor thrombus.
- Top Cited Papers
- 1 March 2017
- Published by Elsevier in European Urology
- Vol. 71 (3) , 462-475
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- 1 March 2017
- Published by Elsevier in European Urology
- Vol. 71 (3) , 462-475
Top Cited PapersUpdated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- 1 December 2016
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 40 (10) , 608-614
Ultrasonido focalizado de alta intensidad con el dispositivo Focal-One®: impacto sobre el antígeno prostático específico y evaluación de la morbilidad durante la experiencia inicial
- 1 December 2016
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 40 (10) , 608-614
Ultrasonido focalizado de alta intensidad con el dispositivo Focal-One®: impacto sobre el antígeno prostático específico y evaluación de la morbilidad durante la experiencia inicial
- 1 September 2016
- Vol. 69 (7) , 446-7
Perirrenal presentation of extranodal Rosai-Dorfman disease.
- 26 August 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (6) , 764-768
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival
Background: Renal cell carcinoma forming a venous tumor thrombus (VTT) in the inferior vena cava (IVC) has a poor prognosis. Recent investigations have been focused on prognostic markers of survival. Thrombus consistency (TC) has been proposed to be of significant value but yet there are conflicting data. The aim of this study is to test the effect of IVC VTT consistency on cancer specific survival (CSS) in a multi‐institutional cohort.Methods: The records of 413 patients collected by the International Renal Cell Carcinoma–Venous Thrombus Consortium were retrospectively analyzed. All patients underwent radical nephrectomy and tumor thrombectomy. Kaplan–Meier estimate and Cox regression analyses investigated the impact of TC on CSS in addition to established clinicopathological predictors.Results: VTT was solid in 225 patients and friable in 188 patients. Median CSS was 50 months in solid and 45 months in friable VTT. TC showed no significant association with metastatic spread, pT stage, perinephric fat invasion, and higher Fuhrman grade. Survival analysis and Cox regression rejected TC as prognostic marker for CSS.Conclusions: In the largest cohort published so far, TC seems not to be independently associated with survival in RCC patients and should therefore not be included in risk stratification models. J. Surg. Oncol. 2016;114:764–768.
- 26 August 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (6) , 764-768
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival
Background: Renal cell carcinoma forming a venous tumor thrombus (VTT) in the inferior vena cava (IVC) has a poor prognosis. Recent investigations have been focused on prognostic markers of survival. Thrombus consistency (TC) has been proposed to be of significant value but yet there are conflicting data. The aim of this study is to test the effect of IVC VTT consistency on cancer specific survival (CSS) in a multi‐institutional cohort.Methods: The records of 413 patients collected by the International Renal Cell Carcinoma–Venous Thrombus Consortium were retrospectively analyzed. All patients underwent radical nephrectomy and tumor thrombectomy. Kaplan–Meier estimate and Cox regression analyses investigated the impact of TC on CSS in addition to established clinicopathological predictors.Results: VTT was solid in 225 patients and friable in 188 patients. Median CSS was 50 months in solid and 45 months in friable VTT. TC showed no significant association with metastatic spread, pT stage, perinephric fat invasion, and higher Fuhrman grade. Survival analysis and Cox regression rejected TC as prognostic marker for CSS.Conclusions: In the largest cohort published so far, TC seems not to be independently associated with survival in RCC patients and should therefore not be included in risk stratification models. J. Surg. Oncol. 2016;114:764–768.